SCHEMBL7702307

SCHEMBL7702307

c1cc(OCCCN2CCCNCC2)cc(-c2n[nH]c3c2Cc2ccccc2-3)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.54
CHEK1 O14757 10/20 0.53
ADORA1 P30542 4/20 0.47
HRH3 Q9Y5N1 4/20 0.47
ADORA2A P29274 3/20 0.47
ADORA3 P0DMS8 2/20 0.47
ADORA2B P29275 2/20 0.47
DRD2 P14416 1/20 0.47
DRD3 P35462 1/20 0.47
MARK3 P27448 2/20 0.46
MARK2 Q7KZI7 2/20 0.46
AURKB Q96GD4 2/20 0.46
RET P07949 1/20 0.46
PDGFRA P16234 1/20 0.46
CDK2 P24941 1/20 0.46
FLT4 P35916 1/20 0.46
RPS6KA3 P51812 1/20 0.46
TYRO3 Q06418 1/20 0.46
CAMK2G Q13555 1/20 0.46
CAMK2D Q13557 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7702517 0.96 KDR (0.57) KDRCHEK1MARK3MARK2AURKB
SCHEMBL7703072 0.96 KDR (0.55) KDRCHEK1MARK3MARK2AURKB
SCHEMBL7172093 0.92 KDR (0.58) KDRCHEK1MARK3MARK2AURKB
SCHEMBL7703663 0.92 CHEK1 (0.62) KDRCHEK1ADORA1HRH3ADORA2A
SCHEMBL7702402 0.89 KDR (0.63) KDRCHEK1ADORA1HRH3ADORA2A
SCHEMBL7700924 0.89 KDR (0.67) KDRCHEK1MARK3MARK2AURKB
SCHEMBL7147015 0.87 KDR (0.59) KDRCHEK1ADORA1HRH3ADORA2A
SCHEMBL7703429 0.86 CHEK1 (0.63) KDRCHEK1MARK3MARK2AURKB
SCHEMBL7140591 0.85 KDR (0.64) KDRCHEK1MARK3MARK2AURKB
SCHEMBL7147004 0.84 KDR (0.68) KDRCHEK1MARK3MARK2AURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed